lobbying: lobbying_activities: 570 rows where filing_year = 2007 and issue_code = "PHA" sorted by filing

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

570 rows where filing_year = 2007 and issue_code = "PHA" sorted by filing_year descending

descending

✎ View and edit SQL

This data as json, CSV (advanced)

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year ▲	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	received_date
502916	WASHINGTON STRATEGIC CONSULTING 08a9e4d9-42b0-4a4f-9a4b-ef812d440d4d	MT	WASHINGTON STRATEGIC CONSULTING	305236	OCTAPHARMA	2007	mid_year	PHA	Education of plasma derived therapies.	Health & Human Services, Dept of (HHS)	20000		2007-06-06T13:57:15-04:00
502917	WASHINGTON STRATEGIC CONSULTING 23520c67-f072-4428-a061-1a6f1125f849	MT	WASHINGTON STRATEGIC CONSULTING	305236	FFF ENTERPRISES	2007	mid_year	PHA	Safe distribution of drugs/biologics.	Health & Human Services, Dept of (HHS)	40000		2007-06-06T13:59:17-04:00
503173	CYBER SECURITY RESEARCH CONSULTANTS, LLC 436f7c17-74e5-4ae2-8c51-5e0018e8181e	MM	CYBER SECURITY RESEARCH CONSULTANTS, LLC	91694	PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION	2007	mid_year	PHA	Prescription Drug Reimportation	HOUSE OF REPRESENTATIVES	30000		2007-07-05T12:19:07-04:00
503182	CYBER SECURITY RESEARCH CONSULTANTS, LLC 1aef09fb-a37e-4d14-ba06-fde704aa7d12	MA	CYBER SECURITY RESEARCH CONSULTANTS, LLC	91694	PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION	2007	mid_year	PHA	Prescription Drug IMportation	HOUSE OF REPRESENTATIVES,SENATE	30000		2007-07-05T15:28:33-04:00
503277	D. LYNN JOHNSON 88420b71-1003-43e6-a5e1-577df4c120d9	MM	D. LYNN JOHNSON	86653	KING PHARMACEUTICALS INC	2007	mid_year	PHA	Contacted a member of the House to ask support for an appropriation to procure and install emergency FDA approved self administered auto-injectors containing atropine and prolidoxime in the Washington Transit Authority Metro Rail System.	HOUSE OF REPRESENTATIVES,SENATE	30000		2007-07-09T00:00:00-04:00
503505	JAMES KERSTEN a8ec17a5-d7d7-4ad2-b5e1-0df1f7201e94	YY	JAMES KERSTEN	289977	WYETH	2007	year_end	PHA	Help educate public policy arena on the importance of affordable access to prescription drugs - human and animal	HOUSE OF REPRESENTATIVES,SENATE	10000		2007-07-12T09:06:51-04:00
503520	JAMES KERSTEN 3d90d827-4645-4d54-a25a-8f317293fe58	MM	JAMES KERSTEN	289977	WYETH	2007	mid_year	PHA	Help educate public policymakers on the importance of affordable human and animal pharmaceuticals	HOUSE OF REPRESENTATIVES,SENATE			2007-07-12T09:29:05-04:00
503909	VORYS, SATER, SEYMOUR AND PEASE LLP 6683f780-64dc-483a-9349-035825949a24	MM	VORYS, SATER, SEYMOUR AND PEASE LLP	40236	SOLVAY PHARMACEUTICALS INC	2007	mid_year	PHA	U.S. Troop Readiness, Veterans' Health, and Iraq Accountability Act of 2007 (H.R. 1591) Departments of Labor, Health and Human Services, and Education and related Agencies Appropriations Act for 2008 (S.1710) FY2007 Emergency Supplemental Appropriations bill (H.R. 2206) U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007 (S.965)	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	20000		2007-07-16T11:03:14-04:00
503927	MARSHALL BRACHMAN 6cb67f14-a5e2-4543-bec1-6e784d9b8bfd	MM	MARSHALL BRACHMAN	6848	STEWART JACKSON PHARMACAL	2007	mid_year	PHA	House Energy and Commerce Committee and Senate HELP Committee; monitor FDA legislation related to regulation of pharmaceutical manufacture	HOUSE OF REPRESENTATIVES,SENATE	12000		2007-07-16T11:55:31-04:00
503930	INDEPENDENT PHARMACY COOPERATIVE 9b316541-ca99-4b9c-993e-37b281027b32	MM	INDEPENDENT PHARMACY COOPERATIVE	313098	INDEPENDENT PHARMACY COOPERATIVE	2007	mid_year	PHA	The Deficit Reduction Act of 2005 requires that Medicaid Federal Upper Limits for generic drugs be based on 250% of the lowest Average Manufacturers Price. Position against the implementation of the new FUL and for new legislation that better defines pharmacy actual aquisition cost. H.R. 971 Position for negotiation rights for small pharmacies. H.R. 1474 (FAST) Position for prompt payment (14 days) to pharmacies under the Medicare Part D program.	HOUSE OF REPRESENTATIVES,SENATE		20000	2007-07-16T12:08:39-04:00
504023	VAN FLEET ASSOCIATES 1b36248b-c413-4f3b-88db-83529da2ef29	MM	VAN FLEET ASSOCIATES	39781	AMERICAN COUNCIL ON REGULATORY COMPLIANCE	2007	mid_year	PHA	Over the counter sales of products that contain Ephedrine amd Pseudoephedrine.	Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES	18000		2007-07-17T10:53:25-04:00
504331	HOLLAND & KNIGHT LLP f624fb39-abd7-4ffc-9b58-776914701047	MM	HOLLAND & KNIGHT LLP	18466	EXPRESS SCRIPTS INC	2007	mid_year	PHA	Reauthorization of the Prescription Drug User Fee Act	HOUSE OF REPRESENTATIVES,SENATE			2007-07-18T12:18:03-04:00
504370	MICHAEL POLLARD 24e7d2f0-155a-4c3e-b3c4-b83da80f1a86	MM	MICHAEL POLLARD	87836	MEDCO HEALTH SOLUTIONS INC	2007	mid_year	PHA	S 3 Medicare Prescription Drug Price Negotiation Act of 2007 S 28 Generics First Act of 2007 S 130 Medicare Cost Contract Extension and Refinement Act of 2007 S 137 Preserving Medicare for All Act of 2007 S 158 Access to Affordable Health Care Act S 173 Medicare Health Savings Accounts Act of 2007 S 242 Pharmaceutical Market Access and Drug Safety Act of 2007 S 250 The Medicare Enhancements for Needed Drugs Act of 2007 S 251 Pharmaceutical Market Access Act of 2007 S 273 Prescription Drug and Health Improvement Act of 2007 S 316 Preserve Access to Affordable Generics Act S 355 The Social Security and Medicare Solvency Commission Act S 358 Genetic Information Nondiscrimination Act of 2007 S 468 Food and Drug Administration Safety Act of 2007 S. 628 - Critical Access to Health Information Technology Act of 2007 S 976 Genomics and Personalized Medicine Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007 S 1082 Prescription Drug User Fee Amendments of 2007 S 1108 Medicare Part D Outreach and Enrollment Enhancement Act of 2007 S 1161 Medicare Medical Nutrition Therapy Act of 2007 S 1198 Catastrophic Health Coverage Promotion Act S 1218 Medicare for All Act S 1307 Medicare Provider Accountability Act S 1338 Access to Medicare Imaging Act of 2007 S 1376 340B Program Improvement and Integrity Act of 2007 S 1408 Health Information Technology Act of 2007 S 1505 Affordable Biologics for Consumers Act S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 S 1695 Biologics Price Competition and Innovation Act of 2007 HR 4 Medicare Prescription Drug Price Negotiation Act of 2007 HR 205 Medicare Prescription Drug Enrollment Extension Act of 2007 HR 493 Genetic Information Nondiscrimination Act of 2007 HR 788 Food and Drug Administration Safety Act of 2007 HR 971 Community Pharmacy Fairness Act of 2007 HR 1218 Medicare Prescription Drug Improvement Act HR 1277 Medicare Prescription Drug Benefits Gap E…	Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	110000		2007-07-18T14:26:35-04:00
504469	DAVIS WRIGHT TREMAINE LLP 102c7e2a-26e9-44e4-aee2-e28a1c3759ae	MM	DAVIS WRIGHT TREMAINE LLP	11721	WALGREEN COMPANY	2007	mid_year	PHA		HOUSE OF REPRESENTATIVES,SENATE	80000		2007-07-19T00:00:00-04:00
504529	TERRY LATANICH 8fde1c32-0b51-4019-8aac-86ac40ae97c6	MM	TERRY LATANICH	284595	MEDCO HEALTH SOLUTIONS INC	2007	mid_year	PHA	S 3 Medicare Prescription Drug Price Negotiation Act of 2007 S 28 Generics First Act of 2007 S 130 Medicare Cost Contract Extension and Refinement Act of 2007 S 137 Preserving Medicare for All Act of 2007 S 158 Access to Affordable Health Care Act S 173 Medicare Health Savings Accounts Act of 2007 S 242 Pharmaceutical Market Access and Drug Safety Act of 2007 S 250 The Medicare Enhancements for Needed Drugs Act of 2007 S 251 Pharmaceutical Market Access Act of 2007 S 273 Prescription Drug and Health Improvement Act of 2007 S 316 Preserve Access to Affordable Generics Act S 355 The Social Security and Medicare Solvency Commission Act S 358 Genetic Information Nondiscrimination Act of 2007 S 468 Food and Drug Administration Safety Act of 2007 S. 628 - Critical Access to Health Information Technology Act of 2007 S 976 Genomics and Personalized Medicine Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007 S 1082 Prescription Drug User Fee Amendments of 2007 S 1108 Medicare Part D Outreach and Enrollment Enhancement Act of 2007 S 1161 Medicare Medical Nutrition Therapy Act of 2007 S 1198 Catastrophic Health Coverage Promotion Act S 1218 Medicare for All Act S 1307 Medicare Provider Accountability Act S 1338 Access to Medicare Imaging Act of 2007 HR 4 Medicare Prescription Drug Price Negotiation Act of 2007 HR 205 Medicare Prescription Drug Enrollment Extension Act of 2007 HR 493 Genetic Information Nondiscrimination Act of 2007 HR 788 Food and Drug Administration Safety Act of 2007 HR 971 Community Pharmacy Fairness Act of 2007 HR 1218 Medicare Prescription Drug Improvement Act HR 1277 Medicare Prescription Drug Benefits Gap Elimination Act of 2007 HR 1282 Medigap Access Improvement Act of 2007 HR 1310 Relief and Elimination of the Medicare Enrollment Deadline Penalty (REMEDY) Act of 2007 HR 1368 Personalized Health Information Act of 2007 HR 1432 Preserve Access to Affordable Generics Act HR 1474 Fair and Speedy Treatment (FAST…	Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	30000		2007-07-19T10:15:25-04:00
504562	MEDCO HEALTH SOLUTIONS, INC 380c91f4-63de-46c9-bcf1-91df19dee884	MM	MEDCO HEALTH SOLUTIONS, INC	89177	MEDCO HEALTH SOLUTIONS INC	2007	mid_year	PHA	S 3 Medicare Prescription Drug Price Negotiation Act of 2007 S 28 Generics First Act of 2007 S 130 Medicare Cost Contract Extension and Refinement Act of 2007 S 137 Preserving Medicare for All Act of 2007 S 158 Access to Affordable Health Care Act S 173 Medicare Health Savings Accounts Act of 2007 S 242 Pharmaceutical Market Access and Drug Safety Act of 2007 S 250 The Medicare Enhancements for Needed Drugs Act of 2007 S 251 Pharmaceutical Market Access Act of 2007 S 273 Prescription Drug and Health Improvement Act of 2007 S 316 Preserve Access to Affordable Generics Act S 355 The Social Security and Medicare Solvency Commission Act S 358 Genetic Information Nondiscrimination Act of 2007 S 468 Food and Drug Administration Safety Act of 2007 S. 628 - Critical Access to Health Information Technology Act of 2007 S 976 Genomics and Personalized Medicine Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007 S 1082 Prescription Drug User Fee Amendments of 2007 S 1108 Medicare Part D Outreach and Enrollment Enhancement Act of 2007 S 1161 Medicare Medical Nutrition Therapy Act of 2007 S 1198 Catastrophic Health Coverage Promotion Act S 1218 Medicare for All Act S 1307 Medicare Provider Accountability Act S 1338 Access to Medicare Imaging Act of 2007 HR 4 Medicare Prescription Drug Price Negotiation Act of 2007 HR 205 Medicare Prescription Drug Enrollment Extension Act of 2007 HR 493 Genetic Information Nondiscrimination Act of 2007 HR 788 Food and Drug Administration Safety Act of 2007 HR 971 Community Pharmacy Fairness Act of 2007 HR 1218 Medicare Prescription Drug Improvement Act HR 1277 Medicare Prescription Drug Benefits Gap Elimination Act of 2007 HR 1282 Medigap Access Improvement Act of 2007 HR 1310 Relief and Elimination of the Medicare Enrollment Deadline Penalty (REMEDY) Act of 2007 HR 1368 Personalized Health Information Act of 2007 HR 1432 Preserve Access to Affordable Generics Act HR 1474 Fair and Speedy Treatment (FAST…	Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		890000	2007-07-19T11:25:09-04:00
504765	FABIANI & COMPANY c3f2fa07-6fd4-474e-9169-e3c856809f40	MM	FABIANI & COMPANY	72576	ALNYLAM PHARMACEUTICALS	2007	mid_year	PHA	R&D dollars to support research	Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	100000		2007-07-20T12:36:27-04:00
505130	AARP b7d8d0cb-dc53-411d-8b1e-6c8a89bb16c5	MM	AARP	1694	AARP	2007	mid_year	PHA	PRESCRIPTION DRUGS PRESCRIPTION DRUGS H.R.4 PRESCRIPTION DRUGS H.R.5631 PRESCRIPTION DRUGS H.R.1536 PRESCRIPTION DRUGS H.R.2184 PRESCRIPTION DRUGS H.R.380 PRESCRIPTION DRUGS H.R.4 PRESCRIPTION DRUGS H.R.5631 PRESCRIPTION DRUGS HJR20, 100, 102 PRESCRIPTION DRUGS H.R.1535 PRESCRIPTION DRUGS H.R.1536 PRESCRIPTION DRUGS H.R.2184 PRESCRIPTION DRUGS H.R.380 PRESCRIPTION DRUGS H.R.4 PRESCRIPTION DRUGS H.R.1536 PRESCRIPTION DRUGS H.R.4 PRESCRIPTION DRUGS S.1082 PRESCRIPTION DRUGS S.242 PRESCRIPTION DRUGS S.3 PRESCRIPTION DRUGS S.623 PRESCRIPTION DRUGS S.3 PRESCRIPTION DRUGS S.623 PRESCRIPTION DRUGS S.1082 PRESCRIPTION DRUGS S.242 PRESCRIPTION DRUGS S.3 PRESCRIPTION DRUGS PRESCRIPTION DRUGS S.623 PRESCRIPTION DRUGS S.3	Administration on Aging,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Telecommunications & Information Administration (NTIA),Office of Management & Budget (OMB),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office		7400000	2007-07-23T17:57:47-04:00
505438	FABIANI & COMPANY 5a81f5a8-e1f6-4b72-a5b5-ca80149617e9	MM	FABIANI & COMPANY	72576	VAXINNATE	2007	mid_year	PHA	Finding Flu Preparedness	Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	120000		2007-07-25T12:16:05-04:00
505726	MAYBERRY & ASSOCIATES, LLC 720c9b08-996e-4d6f-a161-f575e39ffab4	MM	MAYBERRY & ASSOCIATES, LLC	51968	PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION	2007	mid_year	PHA	Food, Drug and Cosmetic Act	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			2007-07-26T00:00:00-04:00
505747	MAYBERRY & ASSOCIATES, LLC ac6e6756-a2c8-4daa-9cd1-d4ffbf2887fa	MM	MAYBERRY & ASSOCIATES, LLC	51968	HEALTHCARE COMPLIANCE PACKAGING COUNCIL	2007	mid_year	PHA	Pharmaceutical regimen compliance	Food & Drug Administration (FDA)			2007-07-26T09:47:08-04:00
505820	NATIONAL ASSOCIATION OF CHAIN DRUG STORES ea606d00-1ebe-43b3-b728-dcbc64899a00	MM	NATIONAL ASSOCIATION OF CHAIN DRUG STORES	26672	NATIONAL ASSOCIATION OF CHAIN DRUG STORES	2007	mid_year	PHA	45. S.1932, the Deficit Reduction Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 46. S. 1548 - Department of Defense Authorization Act for Fiscal Year 2008 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 47. H.R. 1585 - National Defense Authorization Act for Fiscal Year 2008 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 1. H.R. 4241, the Deficit Reduction Act of 2005 2. S. 1932, the Deficit Reduction Act of 2005 3. S. 1695, the Biologics Price Competition and Innovation Act of 2007 4. H.R.1038, Access to Life-Saving Medicine Act 5. S. 623, the Access to Life-Saving Medicine Act 6. H.R. 2900, the Food and Drug Administration Amendments of 2007 7. S. 1082, Food and Drug Administration Revitalization Act 8. H.R.1585, the National Defense Authorization Act 9. S. 1548 - Department of Defense Authorization Act for Fiscal Year 2008 10. S. 1693, the Wired for Health Care Quality Act of 2007 11. H.R. 1952, the National Health Information Incentive Act 12. H.R. 2747, the Methamphetamine Production Prevention Act of 2007 13. S. 1276, the Methamphetamine Production Prevention Act of 2007 14. H.R.1591, the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007 15. S. 3, the Medicare Fair Prescription Drug Price Act of 2007 16. S. 1088, the Lower Prices Reduced With Increased Competition and Efficient Development of Drugs Act 17. H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 18. S.242, the Pharmaceutical Market Access and Drug Safety Act of 2007 19. H.R. 800, the Employee Free Choice Act of 2007 20. S. 596, the Safe Internet Pharmacy Act of 2007 21. H.R.976, Small Business Tax Relief Act of 2007 22. H.R. 970, the Dextromethorphan Distribution Act of 2007 23. H.R. 971, the Community Pharmacy Fairness Act of 2007 24. S. 885, the C…	Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Personnel Management (OPM),SENATE,White House Office		340000	2007-07-26T11:41:40-04:00
505828	MAYBERRY & ASSOCIATES, LLC bacc43aa-0ad5-4ea0-8b4f-affac226ef4b	MM	MAYBERRY & ASSOCIATES, LLC	51968	PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION	2007	mid_year	PHA	Food, Drug and Cosmetic Act	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			2007-07-26T11:51:47-04:00
505987	TIBER CREEK GROUP 00f3c4d2-ee04-4e0c-a1bf-6def7343a807	MM	TIBER CREEK GROUP	20744	MASTERCARD	2007	mid_year	PHA	Drug reimportation legislation; Internet tobacco sales and pharmacy sales.	HOUSE OF REPRESENTATIVES,SENATE	140000		2007-07-26T16:02:12-04:00
506125	MICHAEL L. TINER 141fdc02-ed4f-4f9d-9603-0f7985bd1a4e	MM	MICHAEL L. TINER	38175	PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION	2007	mid_year	PHA		HOUSE OF REPRESENTATIVES,SENATE	20000		2007-07-27T00:00:00-04:00
506190	MICHAEL L. TINER 3ce4a4eb-2d78-42a5-a3a7-46e402cf4f45	MM	MICHAEL L. TINER	38175	AMGEN	2007	mid_year	PHA		HOUSE OF REPRESENTATIVES,SENATE	20000		2007-07-27T00:00:00-04:00
506546	MEREDITH MCGEHEE 35029613-7d3c-434c-a6b3-e1aafedc4885	MM	MEREDITH MCGEHEE	79858	INTERNATIONAL AIDS VACCINE INITIATIVE	2007	mid_year	PHA	funding for programs to develop AIDS vaccine targed toward the developing world; research and development programs aimed at the AIDS epidemic; tax issues affecting AIDS vaccine programs; patent issue on vaccine development; reauthorization of PEPFAR; appropriation for IAVI	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-07-27T14:34:20-04:00
506606	TIBER CREEK GROUP 5fb7c618-34dc-4612-ad0b-eb3a9adb51fb	MM	TIBER CREEK GROUP	20744	AMGEN INC	2007	mid_year	PHA	HR.2900, Food and Drug Administration Amendments Act of 2007.	HOUSE OF REPRESENTATIVES,SENATE	80000		2007-07-27T15:40:52-04:00
506614	TIBER CREEK GROUP edb0ee73-4fc5-4a2b-bd07-9d2dc1ceffb3	MM	TIBER CREEK GROUP	20744	ASTRAZENECA	2007	mid_year	PHA	HR.2900, Food and Drug Administration Amendments Act of 2007.	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-07-27T15:44:55-04:00
506617	TIBER CREEK GROUP 3c6da25b-10f2-4f70-8eda-0d2342ef0c66	MM	TIBER CREEK GROUP	20744	PHRMA	2007	mid_year	PHA	HR.2900, Food and Drug Administration Amendments Act of 2007.	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-07-27T15:46:57-04:00
506656	KAISER FOUNDATION HEALTH PLAN INC. b1a66835-d758-411f-82c8-58015acafa57	MM	KAISER FOUNDATION HEALTH PLAN INC.	21027	KAISER FOUNDATION HEALTH PLAN INC	2007	mid_year	PHA	"Preserve Access to Affordable Generics Act" - S 316 To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, issues relating to health plans. Sponsor: Sen. Kohl	HOUSE OF REPRESENTATIVES,SENATE		320000	2007-07-27T17:18:40-04:00
506929	DUTKO WORLDWIDE, LLC 6714df42-d408-4e03-bb10-ef83c0364a22	MM	DUTKO WORLDWIDE, LLC	12868	MEDIMPACT HEALTHCARE SYSTEMS	2007	mid_year	PHA	Educate Governor's about MedImpact's ability to manage pharmacy benefits. Work with CMS on the role of PBM's in delivering the Medicare Part D benefit and related operational issues. While educating Governors about client and their services.	HOUSE OF REPRESENTATIVES,SENATE	120000		2007-07-30T09:25:19-04:00
507440	PARRY, ROMANI, DECONCINI & SYMMS 68209471-505b-4a47-b772-154ca605c894	MM	PARRY, ROMANI, DECONCINI & SYMMS	30792	INTL ACADEMY OF COMPOUNDING PHARMACISTS	2007	mid_year	PHA	S.1082, Amending the Federal Food, Drug, and Cosmetic Act & the Public Health Service Act H.R.2900, the FDA Amendment of 2007	HOUSE OF REPRESENTATIVES,SENATE	100000		2007-07-30T17:10:35-04:00
507486	CAPITOL TECHNOLOGY AFFAIRS, LLC 13545816-e791-4172-a694-a5cf7382a4f5	MM	CAPITOL TECHNOLOGY AFFAIRS, LLC	294052	WALGREENS	2007	mid_year	PHA	Medicaid	Natl Economic Council (NEC),Office of Management & Budget (OMB)	20000		2007-07-30T20:41:57-04:00
507500	MR. JONATHAN BAND 1ee42ee6-2746-45d6-aa4f-afa14db5a04c	MM	MR. JONATHAN BAND	297215	NETCOALITION COM	2007	mid_year	PHA	Online pharmacies	Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,Library of Congress (LOC),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)			2007-07-31T00:00:00-04:00
507524	FAMILY RESEARCH COUNCIL 23be8dc2-f3a6-4d63-ade2-ed0df2ba378b	MM	FAMILY RESEARCH COUNCIL	14110	FAMILY RESEARCH COUNCIL	2007	mid_year	PHA		HOUSE OF REPRESENTATIVES,SENATE		40000	2007-07-31T00:00:00-04:00
508289	PARRY, ROMANI, DECONCINI & SYMMS f5937a55-8810-4fb0-870f-5e295c30f88d	MM	PARRY, ROMANI, DECONCINI & SYMMS	30792	SIDLEY AUSTIN LLP (FOR SEPRACOR)	2007	mid_year	PHA	Medicare reimbursement issues.	HOUSE OF REPRESENTATIVES,SENATE	120000		2007-07-31T19:11:23-04:00
508343	POLICY ADVOCATES 0933bf10-019d-4e8b-a05b-854cd234c3ae	MM	POLICY ADVOCATES	72018	PHOENIX CAPITAL MANAGEMENT LLC	2007	mid_year	PHA	HR 380/S. 242: To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. S. 980: A bill to amend the Controlled Substances Act to address online pharmacies. S. 596: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of Internet pharmacies.	HOUSE OF REPRESENTATIVES,SENATE	30000		2007-08-01T08:12:47-04:00
508357	POLICY DIRECTIONS INC. 8d1c2231-2a84-4f2e-8b66-308cc08ed130	MM	POLICY DIRECTIONS INC.	31747	ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC )	2007	mid_year	PHA	Antibiotics in animal foods Drug approvals	Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	20000		2007-08-01T09:37:06-04:00
508512	HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 8168d4ca-3f1a-4335-aeb2-6ffd45c72ef2	MM	HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA)	28776	HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)	2007	mid_year	PHA	Drug Safety Importation of prescription drugs Counterfeit pharmaceuticals Pharmaceutical Pedigree requirements Medication Guidelines	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),White House Office		300000	2007-08-01T11:45:04-04:00
508595	CAPITOL HILL CONSULTING GROUP c9ab378c-f975-4a61-9834-d07afac17f26	MM	CAPITOL HILL CONSULTING GROUP	72053	CUBIST PHARMACEUTICALS INC	2007	mid_year	PHA	General pharmaceutical issues	HOUSE OF REPRESENTATIVES,SENATE	60000		2007-08-01T12:15:23-04:00
508607	CAPITOL HILL CONSULTING GROUP 7b41a8a9-d683-4cff-89b2-e40cfd8784ff	MM	CAPITOL HILL CONSULTING GROUP	72053	ELI LILLY AND COMPANY	2007	mid_year	PHA	General pharmaceutical issues pertaining to Eli Lilly and Company.	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-08-01T12:22:34-04:00
508632	CAPITOL HILL CONSULTING GROUP e84d4334-412b-441b-a076-e13f9111d7be	MM	CAPITOL HILL CONSULTING GROUP	72053	PURDUE PHARMA LLP	2007	mid_year	PHA	General pharmaceutical related issues	HOUSE OF REPRESENTATIVES,SENATE	20000		2007-08-01T12:40:58-04:00
508658	CAPITOL HILL CONSULTING GROUP 9e641c06-6c1a-45da-ac7b-8513be27d868	MM	CAPITOL HILL CONSULTING GROUP	72053	DFB PHARMACEUTICALS INC	2007	mid_year	PHA	General pharmaceutical issues pertaining to the company	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-08-01T13:06:29-04:00
508834	CAPITOL HILL CONSULTING GROUP d9bfb6f1-8524-476b-8e16-aa9cd4dded1e	MA	CAPITOL HILL CONSULTING GROUP	72053	CUBIST PHARMACEUTICALS INC	2007	mid_year	PHA	General pharmaceutical issues	HOUSE OF REPRESENTATIVES,SENATE	60000		2007-08-01T14:54:22-04:00
508916	UNIVERSITY OF PITTSBURGH MEDICAL CENTER 74cef759-1fc0-4994-8472-917d02a12701	MM	UNIVERSITY OF PITTSBURGH MEDICAL CENTER	32065	UNIVERSITY OF PITTSBURGH MEDICAL CENTER	2007	mid_year	PHA	Issues related to the cost of prescription pharmaceuticals and the impact of that cost on hospitals and health care providers.	Air Force, Dept of,Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE		520000	2007-08-01T15:28:53-04:00
509385	STEPHANIE WENKERT KANWIT LLC c7078d20-811e-4c7b-a917-d8b057f55990	MM	STEPHANIE WENKERT KANWIT LLC	309572	AMERICA'S HEALTH INSURANCE PLANS INC	2007	mid_year	PHA	Regulatory: issues relating to post-marketing surveillance of drugs and medical devices, and issues relating to medical device recalls, including reporting and reimbursement.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE	45000		2007-08-02T10:46:55-04:00
509439	LEE & SMITH, PC 5c4af472-fb8f-43fd-9c52-a5e87a476259	MM	LEE & SMITH, PC	22440	NORTH DAKOTA STATE UNIVERSITY (NDSU)	2007	mid_year	PHA	FY2008 Labor, HHS, and Education Appropriations Bill North Dakota Telepharmacy Project for Rural Hospitals Center for Advanced Biomedical Materials and Electronics Center for Advanced Bio-Pharmaceutical Research	HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-02T11:16:09-04:00
509519	TIMMONS AND COMPANY, INC. 30b1050c-1b88-4f2c-926e-dc71b6e15f07	MM	TIMMONS AND COMPANY, INC.	38164	TEVA PHARMACEUTICALS USA INC	2007	mid_year	PHA	S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251 - Pharmaceutical Market Access Act of 2007 S. 1082 - Prescription Drug User Fee Amendments of 2007 H.R. 2900 - Food and Drug Administration Amendments Act of 2007 S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. S. 1505 - Affordable Biologics for Consumers Act	HOUSE OF REPRESENTATIVES,SENATE	200000		2007-08-02T12:05:48-04:00
509549	AMERICAN ACADEMY OF FAMILY PHYSICIANS 62d5ac99-b061-4bc4-b07f-3df762c317ed	MM	AMERICAN ACADEMY OF FAMILY PHYSICIANS	1342	AMERICAN ACADEMY OF FAMILY PHYSICIANS	2007	mid_year	PHA	No Bill Number, Implementation of MMA, Simplification of Part D program.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		1250381	2007-08-02T12:16:10-04:00
509780	FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) fe725315-c3cc-4754-8047-ff08adc4a2b3	MM	FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)	86196	PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)	2007	mid_year	PHA	Monitor legislative developments in health care	HOUSE OF REPRESENTATIVES,SENATE	100000		2007-08-02T14:32:36-04:00
509819	BLUE CROSS AND BLUE SHIELD ASSOCIATION ef238de2-7bec-4d91-aa26-a29a8f316c27	MM	BLUE CROSS AND BLUE SHIELD ASSOCIATION	6358	BLUE CROSS AND BLUE SHIELD ASSOCIATION	2007	mid_year	PHA	Biologicals; biogenerics; S623 "Access to Life Saving Medicine Act"	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office		3100000	2007-08-02T14:46:31-04:00
509851	ACADEMY OF MANAGED CARE PHARMACY 39bbe7f0-8362-44ae-9f23-e564d7cad40a	MM	ACADEMY OF MANAGED CARE PHARMACY	48793	ACADEMY OF MANAGED CARE PHARMACY	2007	mid_year	PHA	* Prescription Drug User Fee Act (PDUFA) re-authorization Food and Drug Administration reform efforts: expansion of post-market surveillance programs for prescription drugs; post-market risk management; additional monitoring of direct-to-consumer advertisements for prescription drugs; additional agency funding. Adjustments to Medicaid prescription drug reimbursement rates (calculation of average manufacturer price). Legislation relating to "follow-on" biologic pharmaceuticals. Legislation relating to authorized generic prescription drugs. Importation of prescription drugs/counterfeit drugs. Federal regulation of the practice of pharmacy compounding,	HOUSE OF REPRESENTATIVES,SENATE		285000	2007-08-02T15:04:10-04:00
509975	WELLMARK, INC. b6460932-6a8c-4d53-9ecb-e76b47da1b39	MM	WELLMARK, INC.	40910	WELLMARK INC	2007	mid_year	PHA	Drug patent extensions and market exclusivity issues; Generic Drugs	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE			2007-08-02T16:02:57-04:00
510144	PARRY, ROMANI, DECONCINI & SYMMS 89074cbb-bdf5-4051-b0ac-0bf0a34413db	MM	PARRY, ROMANI, DECONCINI & SYMMS	30792	MILLENNIUM PHARMACEUTICAL	2007	mid_year	PHA	HR 3162 - Chidren's Health and Medicare Protection Act	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-08-02T17:05:57-04:00
510164	AVENUE SOLUTIONS 713f3282-0c11-4dca-99f5-4cd2773c1f17	MM	AVENUE SOLUTIONS	72111	BLUE CROSS BLUE SHIELD ASSOCIATION	2007	mid_year	PHA	Biologics; Biogenerics; S 623 “Access to Life Saving Medicine Act”	HOUSE OF REPRESENTATIVES,SENATE	162000		2007-08-02T17:11:15-04:00
510371	AVENUE SOLUTIONS f7667375-4e3e-4e8b-8f67-43d71410ca96	MM	AVENUE SOLUTIONS	72111	EXPRESS SCRIPTS INC	2007	mid_year	PHA	HR 971 Community Pharmacy Fairness Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007	HOUSE OF REPRESENTATIVES,SENATE	105000		2007-08-03T10:15:13-04:00
510560	TCH GROUP, LLC c6a4e1c3-8051-4036-a3ef-d7b65d667694	MM	TCH GROUP, LLC	51478	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2007	mid_year	PHA	H.R. 1038, S. 623- Bill to amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products. S. 109- Pharmaceutical Market Access Act of 2005: S. 184- Safe Import Act of 2005; H.R. 700, S. 334-Pharmaceutical Market Access and Drug Safety Act of 2005; and S. 930 Food and Drug Administration Safety Act of 2005. S. 1082- Prescription Drug User Fee Act & Drug Safety.	HOUSE OF REPRESENTATIVES,SENATE	120000		2007-08-03T13:00:50-04:00
510567	TCH GROUP, LLC 263115ad-bb75-4f15-bca6-2f0c9ec3717c	MM	TCH GROUP, LLC	51478	SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )	2007	mid_year	PHA	1. S. 334, HR 700, S. 1551, S. 109, HR 2744-Specifically, provisions relating to importation of prescription drugs. 2. S. 930- A bill to amend the Food and Drug Administration Safety Act, with respect to drug safety. 3. S. 1082-Prescription Drug User Fee Act & Drug Safety.	HOUSE OF REPRESENTATIVES,SENATE	60000		2007-08-03T13:04:03-04:00
510706	UNIVERSITY OF CONNECTICUT 1c85df25-291f-4647-98a5-38810d2dc99e	MM	UNIVERSITY OF CONNECTICUT	39382	UNIVERSITY OF CONNECTICUT	2007	mid_year	PHA	S. 1082, Prescription Drug User Fee Amendments 2007, Drug safety related issues.	Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE		100000	2007-08-03T14:50:08-04:00
510728	BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 4eccc939-7b49-4b0b-8a1a-b35685ec71de	MM	BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.	6382	BLUE CROSS AND BLUE SHIELD OF FLORIDA INC	2007	mid_year	PHA	Biologicals; biogenerics; S.623 "Access to Life Saving Medicine Act"	HOUSE OF REPRESENTATIVES,SENATE		360000	2007-08-03T14:53:20-04:00
511019	MRS. DIANNE KUBE 372588cd-07ce-469e-bba8-65bf2d2c3197	MM	MRS. DIANNE KUBE	310756	COMMUNITY ONCOLOGY ALLIANCE	2007	mid_year	PHA	Issues pertaining to Community Medical Oncology Practices and Pharmacy Departments in the Community Oncology Practice. ASP, Part B Drugs, Medicare Advantage, Part D, Formulary Issues, Access to Chemo Treatments, ESA Policy Rule Changes at CMS, Reimbursement and Coding for Services and Medications. HR 1190 and S 1750.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE	87000		2007-08-03T18:15:40-04:00
511139	MCKENNA, LONG & ALDRIDGE 9f0c605a-a11c-4338-9851-80e4e06f016a	MM	MCKENNA, LONG & ALDRIDGE	76913	BARR LABORATORIES INC	2007	mid_year	PHA	Regulatory and policy issues for drug products	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-08-04T17:48:13-04:00
511273	MCDERMOTT WILL & SCHULTE LLP 1be1f45d-b5af-4391-93b7-1dd9610520bf	MM	MCDERMOTT WILL & SCHULTE LLP	24338	RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION	2007	mid_year	PHA	Amendment to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	120000		2007-08-06T09:21:07-04:00
511429	CLAUDIA SCHLOSBERG f8e6300b-b524-4366-b58d-98e57fd25341	MM	CLAUDIA SCHLOSBERG	318130	EXCELLERX INC	2007	mid_year	PHA	Medication therapy management; e-prescribing	Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),SENATE			2007-08-06T10:47:53-04:00
511466	CHAMBER OF COMMERCE OF THE U.S.A. a37cdc95-edc5-40b4-bb8c-2ae8227ff632	MM	CHAMBER OF COMMERCE OF THE U.S.A.	38756	CHAMBER OF COMMERCE OF THE U.S.A.	2007	mid_year	PHA	H.R. 4 Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 118 To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries S. 3 Medicare Prescription Drug Price Negotiation Act of 2007 S. 250 Medicare Enhancements for Needed Drugs Act of 2007 S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007	Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Federal Aviation Administration (FAA),Federal Communications Commission (FCC),Federal Highway Administration (FHA),Federal Trade Commission (FTC),Federal Transit Administration (FTA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Aeronautics & Space Administration (NASA),Natl Labor Relations Board (NLRB),Natl Oceanic & Atmospheric Administration (NOAA),Natl Security Council (NSC),Occupational Safety & Health Administration (OSHA),Office of Management & Budget (OMB),Office of the Vice President of the United States,Patent & Trademark Office (PTO),Pension Benefit Guaranty Corporation (PBGC),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Coast Guard (USCG),U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office		11780000	2007-08-06T10:56:57-04:00
511538	UPS (UNITED PARCEL SERVICE) b8a19eca-823b-4aa2-821e-44ce55360217	MM	UPS (UNITED PARCEL SERVICE)	39223	UPS (UNITED PARCEL SERVICE)	2007	mid_year	PHA	Pedigree Pharmaceutical Distribution	Commerce, Dept of (DOC),Government Accountability Office (GAO),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office		1173762	2007-08-06T11:30:06-04:00
511728	INTERNATIONAL COMMERCE DEVELOPMENT CORP f8e9f5c0-87e0-4ee8-9db9-94642bd9b085	MM	INTERNATIONAL COMMERCE DEVELOPMENT CORP	286278	AMPHASTAR PHARMACEUTICALS INC	2007	mid_year	PHA	Seeking generic pharmaceuticals approvals for client from the FDA and EPA.	Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	100000		2007-08-06T12:23:15-04:00
511738	340B HEALTH 819daf70-39ea-4f03-821c-424568e18103	MM	340B HEALTH	316434	340B HEALTH	2007	mid_year	PHA	16. Specific Lobbying Issues: Proposed guidelines from the Health Resources & Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R 2606),	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)		200000	2007-08-06T12:25:23-04:00
511767	JENNINGS POLICY STRATEGIES c7d14bcb-5dca-463d-8d95-afb3914061bc	MM	JENNINGS POLICY STRATEGIES	64656	CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	2007	mid_year	PHA	-Advocate for biopharmaceutical cost-containment policies aimed at creating an abbreviated pathway for access to generic biologic medications (including H.R. 1038 and S. 623)	HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-06T12:32:48-04:00
511785	JENNINGS POLICY STRATEGIES d256121c-c70d-41bd-8650-88d057a0f855	MM	JENNINGS POLICY STRATEGIES	64656	COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET	2007	mid_year	PHA	-Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promote competition in the pharmaceutical marketplace, including S. 623 and H.R. 1038	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-08-06T12:35:58-04:00
511832	VAN SCOYOC ASSOCIATES 67ccf9a2-d98c-4aa8-a7bb-2374cb57d3c5	MM	VAN SCOYOC ASSOCIATES	39837	UNIVERSITY OF CONNECTICUT	2007	mid_year	PHA	S.1082, Prescription Drug User Fee Amendments 2007, Drug safety related issues.	Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-06T12:40:18-04:00
511854	VAN SCOYOC ASSOCIATES 13da5427-d62c-4548-98bc-272d67fc008b	MM	VAN SCOYOC ASSOCIATES	39837	UNIVERSITY OF MARYLAND BALTIMORE	2007	mid_year	PHA	H.R. 3093/S.1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2008, NIST funding issues. S.1082, Prescription Drug User Fee Amendments, 2007, Drug safety related issues. H.R. 2900, Food and Drug Administration Amendments Act of 2007, drug safety related issues.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE	60000		2007-08-06T12:42:31-04:00
511863	JENNINGS POLICY STRATEGIES 997bd65a-d4f0-4fb4-b210-298d6357df93	MM	JENNINGS POLICY STRATEGIES	64656	GENERAL MOTORS CORP	2007	mid_year	PHA	including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for cost containment policies	HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-06T12:44:36-04:00
511883	JENNINGS POLICY STRATEGIES ebc220f6-b6a8-479f-b200-4b0fe2181243	MM	JENNINGS POLICY STRATEGIES	64656	GENERIC PHARMACEUTICAL ASSOCIATION	2007	mid_year	PHA	-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)	HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-06T12:46:23-04:00
511894	VAN SCOYOC ASSOCIATES f2a44626-7a49-41e4-9050-b248825af3e5	MM	VAN SCOYOC ASSOCIATES	39837	UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE	2007	mid_year	PHA	H.R. 2900, Food and Drug Administration Amendments Act of 2007, drug safety related issues. H.R. 3161/S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2008, FDA and USDA funding initiatives. S.1082, Prescription Drug User Fee Amendments, 2007, Drug safety related issues.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-06T12:47:31-04:00
511910	JENNINGS POLICY STRATEGIES f9719975-1f0b-47df-a023-4a4bd20aa550	MM	JENNINGS POLICY STRATEGIES	64656	MOMENTA PHARMACEUTICALS INC	2007	mid_year	PHA	-Advocate for biopharmaceutical cost-containment policies aimed at creating an abbreviated pathway for access to generic biologic medications (including H.R. 1038 and S. 623).	HOUSE OF REPRESENTATIVES,SENATE	90000		2007-08-06T12:49:43-04:00
512487	JAMES P. KEESE 69bdd418-93bd-453b-b7b5-3aa3e0c0f251	MM	JAMES P. KEESE	74556	TEVA PHARMACEUTICALS USA	2007	mid_year	PHA	H.R. 1038 Access to Life-Saving Medicine Act - all provisions S.1082 Food and Drug Administration Revitalization Act - all provisions S. 1088 Lower PRICED Drugs Act- all provisions S.1505 Affordable Biologics for Consumers Act - all provisions S. 1695 Biologics Price Competition and Innovation Act of 2007- all provisions H.R. 1956 The Patient Protection and Innovative Biologic Medicines Act - all provisions H.R. 2900 Food and Drug Administration Amendments Act of 2007 - all provisions S. 25, Citizen Petition Fairness and Accuracy Act of 2007 - all provisions S.623, Access to Life-Saving Medicine Act - all provisions S. 438, Fair Prescription Drug Competition Act - all provisions H.R. 806, Fair Prescription Drug Competition Act - all provisions	Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)	80000		2007-08-06T16:01:59-04:00
512498	NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS 26d2bd36-4cb2-44fb-aa48-259fd28ff594	MM	NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS	26706	NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS	2007	mid_year	PHA	Drug Discount Program (Section 340B of the Public Health Service Act); Mediare Part D.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),President of the U.S.,SENATE		280000	2007-08-06T16:04:05-04:00
512691	ALSTON & BIRD LLP a3b9fd12-e1e4-4774-9626-1f06e29d2a56	MM	ALSTON & BIRD LLP	1182	ENDO PHARMACEUTICALS	2007	mid_year	PHA	Prescription Drug User Fee Act amendments/legislation	HOUSE OF REPRESENTATIVES,SENATE	20000		2007-08-06T17:28:25-04:00
512779	ALSTON & BIRD LLP 7e49ce4b-8de8-4816-911e-13020b406998	MM	ALSTON & BIRD LLP	1182	MYLAN LABORATORIES	2007	mid_year	PHA	Generic drug and biogeneric drug issues, Average Manufacturer's Price proposals and legislation	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-06T18:13:52-04:00
512900	NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS 20bdbc54-0b05-4a45-8af7-ad6d3af7a35d	MA	NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS	26706	NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS	2007	mid_year	PHA	Drug Discount Program (Section 340B of the Public Health Service Act); Mediare Part D.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),President of the U.S.,SENATE		280000	2007-08-07T00:00:00-04:00
512928	MASTERCARD WORLDWIDE 334be1db-7c29-4f48-81a4-1487fa7d1bcc	MM	MASTERCARD WORLDWIDE	23997	MASTERCARD WORLDWIDE	2007	mid_year	PHA		HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE,Treasury, Dept of		880000	2007-08-07T00:00:00-04:00
512955	PODESTA GROUP, INC. 61cc3ddf-2007-46b0-bfc6-8ce45972f078	MM	PODESTA GROUP, INC.	31680	MATTOON & ASSOCIATES LLC	2007	mid_year	PHA	S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	40000		2007-08-07T07:51:41-04:00
512972	PODESTA GROUP, INC. 92ff5f18-aaf1-4a5b-b5be-06babfaeee87	MT	PODESTA GROUP, INC.	31680	PFIZER INC	2007	mid_year	PHA	FDA/PDUFA reform H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions	HOUSE OF REPRESENTATIVES,SENATE	40000		2007-08-07T07:56:51-04:00
513322	POWERS PYLES SUTTER & VERVILLE, P.C. ef8c33fb-6bfd-428d-b315-38c0258967cf	MM	POWERS PYLES SUTTER & VERVILLE, P.C.	32008	340B HEALTH	2007	mid_year	PHA	Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)	31000		2007-08-07T11:53:06-04:00
513693	STANTON PARK GROUP f566e760-6840-42ac-9176-78eac03d7f5e	MM	STANTON PARK GROUP	83717	BARR LABORATORIES	2007	mid_year	PHA	H.R.3161, S.1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act H.R. 2900, S.1082, Food and Drug Administration Reform	HOUSE OF REPRESENTATIVES,SENATE	60000		2007-08-07T14:07:23-04:00
513985	THE NORMANDY GROUP, LLC e8ba7820-d02f-4281-9073-4d56e8827992	MM	THE NORMANDY GROUP, LLC	306636	GENENTECH	2007	mid_year	PHA	General health care issues.	HOUSE OF REPRESENTATIVES,SENATE	100000		2007-08-07T15:24:20-04:00
514695	PD FRAZER CONSULTING, INC. 80434a74-0059-49f6-a456-a79ff91134d7	MM	PD FRAZER CONSULTING, INC.	65998	CANADA INTERNATIONAL PHARMACY ASSOCIATION	2007	mid_year	PHA	Monotoring development of the proposed bills on importation of prescription drugs	HOUSE OF REPRESENTATIVES,SENATE	60000		2007-08-08T10:29:32-04:00
515016	TROUTMAN STATEGIES 75ee925d-4e54-4b51-a323-0a791e8d81ac	MM	TROUTMAN STATEGIES	81511	BRANDED PHARMACEUTICAL ASSOCIATION	2007	mid_year	PHA	Seek legislative and regulatory support for Desi drugs	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	60000		2007-08-08T11:56:12-04:00
515045	GRISSO CONSULTING GROUP, LLC 7fa928c0-b104-499f-a0ee-153ad01cdb52	MM	GRISSO CONSULTING GROUP, LLC	291550	HOFFMAN - LAROCHE INC	2007	mid_year	PHA	Monitor legislation/regulation	HOUSE OF REPRESENTATIVES,SENATE	80000		2007-08-08T12:06:37-04:00
515273	3M COMPANY 0dd3c44b-2ab4-458f-9862-e128202cec28	MM	3M COMPANY	25465	3M COMPANY	2007	mid_year	PHA		Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Government Printing Office (GPO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA)		1040712	2007-08-08T13:39:48-04:00
515411	GIBSON, DUNN & CRUTCHER LLP 3b9c0e3c-2d04-480c-9385-3f92d38b5a62	MM	GIBSON, DUNN & CRUTCHER LLP	16178	HOFFMANN-LAROCHE INC	2007	mid_year	PHA	Amendment o S. 1145 (Patent Reform Bill) to include clarification to ensure uniform application of federal infringement law.	SENATE	20000		2007-08-08T14:09:47-04:00
515452	PODESTA GROUP, INC. 9f1165b0-d928-4a32-b7ab-b3ba79ec578a	MM	PODESTA GROUP, INC.	31680	COVIDIEN	2007	mid_year	PHA	Average Manufacturer Price (AMP) changes	HOUSE OF REPRESENTATIVES,SENATE	20000		2007-08-08T14:21:28-04:00
515817	TARPLIN, DOWNS & YOUNG, LLC 90373ef9-2326-4149-ab86-5b0bddcebc6b	MM	TARPLIN, DOWNS & YOUNG, LLC	304736	HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)	2007	mid_year	PHA	***, no specific bill(s), Pedigree, Importation, Drug Safety H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 S. 1082 - Prescription Drug User Fee Amendments of 2007/Food and Drug Administration Revitalization Act H.R. 2900 - Food and Drug Administration Amendments of 2007	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	100000		2007-08-08T15:39:19-04:00
515955	TARPLIN, DOWNS & YOUNG, LLC 8b6106cc-0efc-4e2c-9f91-d0f7278f0dcc	MM	TARPLIN, DOWNS & YOUNG, LLC	304736	ADVAMED	2007	mid_year	PHA	MDUFMA, Medical Device User Fees, Clinical Trials, Pediatrics, Drug Safety: S. 1082 - Prescription Drug User Fee Amendments of 2007 H.R. 2900 - Food and Drug Administration Amendments of 2007	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	120000		2007-08-08T16:05:34-04:00
516174	VERN CLARK & ASSOCIATES, INC. 6a99cd9e-b2f8-4c58-98c2-97ea39874d9b	MM	VERN CLARK & ASSOCIATES, INC.	9421	WILMER CUTLER PICKERING HALE & DORR (ON BEHALF OF THE MEDICINES COMPANY)	2007	mid_year	PHA	Restoration of patent rights.	SENATE	45000		2007-08-08T17:12:19-04:00
516182	VERN CLARK & ASSOCIATES, INC. 54e1afc2-3741-476e-bee9-8a98e677bed1	MM	VERN CLARK & ASSOCIATES, INC.	9421	AMERISOURCEBERGEN	2007	mid_year	PHA	Deficit Reduction Act and implementing regulations, focusing on Medicaid Reform.	SENATE	45000		2007-08-08T17:15:27-04:00
516400	WALGREEN COMPANY 17f23e5f-63bf-4a0a-b055-12fb0ab81cec	MM	WALGREEN COMPANY	309071	WALGREEN COMPANY	2007	mid_year	PHA	S. 1082, FDA Revitalization Act of 2007 as relates to MedGuides for prescription drugs, internet pharmacy regulation, and anti-counterfeiting of prescription drugs (track and trace); Medicare Part D as related to "fix" with regards to enrollment processing period -- no legislation introduced specific to this; National Provider ID (NPI) as related to date of implementation and look to delay with Administration (CMS) and Congress--no specific legislation. Medicaid prescription drug reimbursement as related to AMP (average manufacturer's price) and FULs (federal upper limits)--no specific legislation yet introduced during this timeframe; H.R. 2567, Medicare Home Infusion Pharmacy Coverage Act of 2007 as it relates to provisions for meaningful Medicare home infusion of prescription drugs benefit; H.R.2900, FDA Amendments Act of 2007, as related to provision dealing with MedGuides required for select prescription drugs;	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		500000	2007-08-08T22:24:30-04:00
516617	NATIONAL RIGHT TO LIFE COMMITTEE 78550792-e67e-4391-ab17-89719dee499f	MM	NATIONAL RIGHT TO LIFE COMMITTEE	28481	NATIONAL RIGHT LIFE COMMITTEE	2007	mid_year	PHA		Air Force, Dept of,Army, Dept of (Other),Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Navy, Dept of,Office of the Vice President of the United States,SENATE,State, Dept of (DOS)		418305	2007-08-09T08:41:55-04:00

Advanced export

JSON shape: default, array, newline-delimited, object

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);